Show Notes
In this episode of the Good GP, host Dr Maria Li welcomes back Dr Katherine Wyld, endocrinologist, for the third and final part of the series on hormone pseudoscience. Focusing on adrenal hormone-related misinformation, commonly encountered both in general practice and on social media. Dr Wyld tackles the adrenal hormone-related prevalent misinformations, including:
The widespread misinformation about adrenal hormones, especially related to cortisol, circulating on social media and online platforms. Cortisol testing requires careful consideration of context and timing, as cortisol levels fluctuate significantly throughout the day. Dr Wyld clarifies that single-point cortisol measurements are rarely clinically meaningful, and that salivary and urine cortisol tests should only be used in specific, evidence-based situations. Dutch testing (dried urine testing for hormones) is not supported by endocrine societies due to lack of evidence, questionable logic, and high cost. “Adrenal fatigue” is not a real or recognized medical condition; there is no scientific evidence or data to support this concept. High cortisol is commonly blamed for stress, anxiety, weight gain, and fatigue, but it is rarely the cause unless clear evidence of Cushing’s syndrome is present. Features of Cushing’s syndrome to look for include diabetes, hypertension, significant unexplained weight gain, skin changes, and proximal myopathy.
Sharing strategies for GPs when faced with unfamiliar symptoms or patient requests based on pseudoscientific information. Dr Wyld encourages clinicians to be honest about knowledge gaps, consult reputable sources, and maintain open communication with patients.
Links & Resources: Endocrine Society of Australia - https://www.endocrinesociety.org.au/ US Endocrine Society - https://www.endocrine.org/ Adrenal Fatigue patient handout - https://www.endocrine.org/patient-engagement/endocrine-library/adrenal-fatigue
The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network
If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information.
More from The Good GP
In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care.
In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD).
In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and expert in communicable diseases, about H5N1 avian influenza and pertussis.